دورية أكاديمية
أعرض في EDS

The potential benefit of metformin to reduce delirium risk and mortality: a retrospective cohort study.

التفاصيل البيبلوغرافية
العنوان: The potential benefit of metformin to reduce delirium risk and mortality: a retrospective cohort study.
المؤلفون: Yamanashi T; Stanford University School of Medicine, Department of Psychiatry and Behavioral Sciences, Palo Alto, CA 94305, USA.; University of Iowa Carver College of Medicine, Department of Psychiatry, Iowa City, IA 52242, USA.; Tottori University Faculty of Medicine, Department of Neuropsychiatry, Yonago-Shi, Tottori, Japan., Anderson ZE; University of Iowa Carver College of Medicine, Department of Psychiatry, Iowa City, IA 52242, USA., Modukuri M; University of Iowa Carver College of Medicine, Department of Psychiatry, Iowa City, IA 52242, USA., Chang G; University of Iowa Carver College of Medicine, Department of Psychiatry, Iowa City, IA 52242, USA., Tran T; University of Iowa Carver College of Medicine, Department of Psychiatry, Iowa City, IA 52242, USA., Marra PS; University of Iowa Carver College of Medicine, Department of Psychiatry, Iowa City, IA 52242, USA., Wahba NE; University of Iowa Carver College of Medicine, Department of Psychiatry, Iowa City, IA 52242, USA., Crutchley KJ; University of Iowa Carver College of Medicine, Department of Psychiatry, Iowa City, IA 52242, USA., Sullivan EJ; University of Iowa Carver College of Medicine, Department of Psychiatry, Iowa City, IA 52242, USA., Jellison SS; University of Iowa Carver College of Medicine, Department of Psychiatry, Iowa City, IA 52242, USA., Comp KR; University of Iowa Carver College of Medicine, Department of Psychiatry, Iowa City, IA 52242, USA., Akers CC; University of Iowa Carver College of Medicine, Department of Psychiatry, Iowa City, IA 52242, USA., Meyer AA; University of Iowa Carver College of Medicine, Department of Psychiatry, Iowa City, IA 52242, USA., Lee S; University of Iowa Carver College of Medicine, Department of Emergency Medicine, Iowa City, IA 52242, USA., Iwata M; Tottori University Faculty of Medicine, Department of Neuropsychiatry, Yonago-Shi, Tottori, Japan., Cho HR; University of Iowa College of Public Health, Department of Biostatistics, Iowa City, IA 52242, USA., Shinozaki E; University of Iowa Carver College of Medicine, Department of Internal Medicine, Iowa City, IA 52242, USA., Shinozaki G; Stanford University School of Medicine, Department of Psychiatry and Behavioral Sciences, Palo Alto, CA 94305, USA.; University of Iowa Carver College of Medicine, Department of Psychiatry, Iowa City, IA 52242, USA.
المصدر: Aging [Aging (Albany NY)] 2022 Nov 17; Vol. 14 (22), pp. 8927-8943. Date of Electronic Publication: 2022 Nov 17.
نوع المنشور: Journal Article
اللغة: English
بيانات الدورية: Publisher: Impact Journals, LLC Country of Publication: United States NLM ID: 101508617 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1945-4589 (Electronic) Linking ISSN: 19454589 NLM ISO Abbreviation: Aging (Albany NY) Subsets: MEDLINE
أسماء مطبوعة: Original Publication: Albany, NY : Impact Journals, LLC
مواضيع طبية MeSH: Metformin*/therapeutic use , Diabetes Mellitus, Type 2*/complications , Diabetes Mellitus, Type 2*/drug therapy , Delirium*/epidemiology , Delirium*/prevention & control, Humans ; Hypoglycemic Agents/therapeutic use ; Retrospective Studies ; Risk Factors
مستخلص: Purpose: Metformin has been reported to improve age-related disorders, including dementia, and to lower mortality. This study was conducted to investigate whether metformin use lower delirium risk, as well as long-term mortality.
Methods: In this retrospective cohort study, previously recruited 1,404 subjects were analyzed. The relationship between metformin use and delirium, and the relationship between metformin use and 3-year mortality were investigated.
Main Findings: 242 subjects were categorized into a type 2 diabetes mellitus (DM)-without-metformin group, and 264 subjects were categorized into a DM-with-metformin group. Prevalence of delirium was 36.0% in the DM-without-metformin group, and 29.2% in the DM-with-metformin group. A history of metformin use reduced the risk of delirium in patients with DM (OR, 0.50 [95% CI, 0.32 to 0.79]) after controlling for confounding factors. The 3-year mortality in the DM-without-metformin group (survival rate, 0.595 [95% CI, 0.512 to 0.669]) was higher than in the DM-with-metformin group (survival rate, 0.695 [95% CI, 0.604 to 0.770]) (p=0.035). A history of metformin use decreased the risk of 3-year mortality after adjustment for confounding factors (HR, 0.69 [95% CI, 0.48 to 0.98]).
Conclusions: Metformin use may lower the risk of delirium and mortality in DM patients.
References: Intern Med J. 2012 May;42(5):484-91. (PMID: 22372522)
Ann Intern Med. 2019 Oct 1;171(7):485-495. (PMID: 31476770)
Eur J Endocrinol. 2019 Nov;181(5):499-507. (PMID: 31437816)
Neurology. 2017 Oct 31;89(18):1877-1885. (PMID: 28954880)
N Engl J Med. 2013 Aug 8;369(6):540-8. (PMID: 23924004)
Ann Fam Med. 2019 Jul;17(4):352-362. (PMID: 31285213)
N Engl J Med. 2006 Mar 16;354(11):1157-65. (PMID: 16540616)
Neurobiol Aging. 2020 Oct;94:227-235. (PMID: 32650186)
Indian J Psychiatry. 2018 Feb;60(Suppl 3):S329-S340. (PMID: 29535468)
Nat Rev Neurol. 2009 Apr;5(4):210-20. (PMID: 19347026)
Ann Intern Med. 2019 Oct 1;171(7):474-484. (PMID: 31476766)
Crit Care Med. 2018 Sep;46(9):1444-1449. (PMID: 29957712)
Diabetes Care. 2002 Dec;25(12):2244-8. (PMID: 12453968)
Cell Metab. 2020 Jul 7;32(1):15-30. (PMID: 32333835)
Sci Rep. 2021 Jan 11;11(1):304. (PMID: 33431928)
Ageing Res Rev. 2020 Dec;64:101174. (PMID: 32971255)
J Alzheimers Dis. 2019;68(4):1699-1710. (PMID: 30958364)
Brain Commun. 2021 Mar 13;3(2):fcab037. (PMID: 34136808)
Age Ageing. 2021 Sep 11;50(5):1445-1453. (PMID: 33984129)
Gerontology. 2019;65(6):581-590. (PMID: 31522175)
Br J Psychiatry. 2021 Aug 02;:1-8. (PMID: 35049468)
JAMA. 2001 Dec 5;286(21):2703-10. (PMID: 11730446)
Psychiatry Clin Neurosci. 2018 Dec;72(12):856-863. (PMID: 30246448)
Neurobiol Aging. 2021 Sep;105:310-317. (PMID: 34192631)
J Psychiatr Res. 2020 Oct;129:61-65. (PMID: 32590150)
J Clin Endocrinol Metab. 2016 Apr;101(4):1754-61. (PMID: 26900641)
J Diabetes Complications. 2017 Apr;31(4):679-686. (PMID: 28190681)
J Clin Psychiatry. 2019 Sep 3;80(5):. (PMID: 31483958)
Lancet. 1998 Sep 12;352(9131):854-65. (PMID: 9742977)
Diabetes Obes Metab. 2014 Nov;16(11):1165-73. (PMID: 25041462)
Bone Marrow Transplant. 2013 Mar;48(3):452-8. (PMID: 23208313)
N Engl J Med. 2013 Oct 3;369(14):1306-16. (PMID: 24088092)
J Am Geriatr Soc. 2021 Jan;69(1):140-147. (PMID: 32905636)
J Diabetes Res. 2016;2016:4847812. (PMID: 27761470)
Nature. 2018 Sep;561(7721):45-56. (PMID: 30185958)
Res Theory Nurs Pract. 2003 Spring;17(1):31-50. (PMID: 12751884)
Diabetes Obes Metab. 2012 Jan;14(1):23-9. (PMID: 21812892)
J Am Geriatr Soc. 2005 Feb;53(2):312-8. (PMID: 15673358)
Medicine (Baltimore). 2020 Jul 17;99(29):e21236. (PMID: 32702900)
Sci Rep. 2021 Jul 9;11(1):14211. (PMID: 34244577)
J Clin Med. 2019 May 10;8(5):. (PMID: 31083442)
Int J Geriatr Psychiatry. 2018 Nov;33(11):1428-1457. (PMID: 29278283)
Brain Res. 2016 Aug 1;1644:149-60. (PMID: 27174003)
Aging (Albany NY). 2020 Jan 16;12(2):1087-1103. (PMID: 31945013)
BMJ Open Diabetes Res Care. 2020 Jul;8(1):. (PMID: 32719079)
Lancet. 2014 Mar 8;383(9920):911-22. (PMID: 23992774)
Ageing Res Rev. 2021 Jan;65:101205. (PMID: 33137510)
Int J Biol Sci. 2019 Mar 10;15(5):1010-1019. (PMID: 31182921)
JAMA. 2021 Apr 27;325(16):1640-1649. (PMID: 33904867)
Diabetes Care. 2010 Feb;33(2):322-6. (PMID: 19918015)
Cell Metab. 2016 Jun 14;23(6):1060-1065. (PMID: 27304507)
Arch Intern Med. 2002 Feb 25;162(4):457-63. (PMID: 11863480)
J Neuropsychiatry Clin Neurosci. 2001 Spring;13(2):229-42. (PMID: 11449030)
Circ Res. 2016 Aug 19;119(5):652-65. (PMID: 27418629)
N Engl J Med. 2018 Dec 27;379(26):2506-2516. (PMID: 30346242)
فهرسة مساهمة: Keywords: aging; delirium; diabetes mellitus; metformin; mortality
المشرفين على المادة: 9100L32L2N (Metformin)
0 (Hypoglycemic Agents)
تواريخ الأحداث: Date Created: 20221118 Date Completed: 20221207 Latest Revision: 20221213
رمز التحديث: 20231215
مُعرف محوري في PubMed: PMC9740381
DOI: 10.18632/aging.204393
PMID: 36399107
قاعدة البيانات: MEDLINE
الوصف
تدمد:1945-4589
DOI:10.18632/aging.204393